EyePoint, Inc. is under investigation by Pomerantz LLP for potential securities fraud following disappointing Phase 3 trial results for its drug DURAVYU™. The trial failed to meet its primary endpoint compared to a competitor drug, leading to a 66.98% drop in EyePoint's stock price on August 17, 2026. The investigation will determine if EyePoint and its executives engaged in unlawful business practices. Investors affected by the stock drop are encouraged to contact Pomerantz LLP for possible legal action.
EyePoint, Inc. is the subject of a legal investigation following its Phase 3 trial results. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: out of 91 priced health-sector US stocks, 59 rose and 31 fell. Notable movers include SANA at USD 3.12 with a 6.85% increase, INO at USD 1.22 with a 6.09% increase, and ABCL at USD 12.38 with a 6.08% increase.
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
Barclays has lowered its price target for Netflix shares from $80 to $70 due to concerns over slower revenue growth and rising content costs, especially for live programming. Despite Netflix's large subscriber base of 325 million, the company faces p...
The LAPTOP token experienced a dramatic price surge from $0.05 to $317 in under two minutes before crashing 98% within an hour. Hunter Biden blamed the collapse on market makers who manipulated liquidity by initially contributing minimal funds and th...
A Bitcoin wallet that had been inactive for over 15 years moved 28.46 BTC, valued at about $2.43 million, on October 6, 2026. The coins were originally received in June 2011, implying a massive estimated gain of over 582,000% based on an acquisition ...
